EUREPA 0.5MG TAB
₹151.88
Eurepa 0.5mg Tablet is a medicine containing Repaglinide used in the management of type 2 diabetes mellitus.
Description
Eurepa 0. 5mg Tablet with composition Repaglinide is a medicine commonly used to treat type 2 diabetes mellitus. It belongs to the class of medications called meglitinides. Repaglinide works by stimulating the release of insulin from the pancreas, which helps to control blood sugar levels. Eurepa 0. 5mg Tablet is prescribed to individuals with type 2 diabetes who cannot manage their blood sugar levels through diet and exercise alone. It is effective in lowering blood sugar levels after meals. The tablet is usually taken orally, usually 15 minutes before each main meal. 5mg Tablet. Some common side effects may include nausea, hypoglycemia, headache, and weight gain. It is advised to seek medical attention if any severe side effects occur. Overall, Eurepa 0. 5mg Tablet is an effective medication for managing blood sugar levels in individuals with type 2 diabetes.
Additional information
| Marketed by | |
|---|---|
| Composition | |
| Dosage form | TABLET |
| Prescription | REQUIRED |
| Therapeutic use | ANTI DIABETICS |
